Neurontin vs. Profen: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Neurontin and Profen. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 755,478 people who take Neurontin and Profen, and is updated regularly.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.
What is Profen?
Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
755,478 people who take Neurontin and Profen are studied.
Drugs being compared in this study:
- Profen (ibuprofen)
- Neurontin (gabapentin)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Neurontin:
- not at all: 5.8100000000000005 %
- somewhat: 29.6 %
- moderate: 35.57 %
- high: 21.07 %
- very high: 7.95 %
Profen:
- not at all: 3.08 %
- somewhat: 24.09 %
- moderate: 38.13 %
- high: 26.65 %
- very high: 8.05 %
Want to compare Neurontin with Profen?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Profen:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on gabapentin and ibuprofen (the active ingredients of Neurontin and Profen, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Headache in Hydrocodone Bitartrate And Acetaminophen, how severe and when it was recovered? - 3 seconds ago
- Wellbutrin and Gastroesophageal Reflux Disease for Women aged 50-59 - 5 seconds ago
- Wellbutrin and Gastrooesophageal Reflux Disease for Women aged 50-59 - 5 seconds ago
- Wellbutrin and Reflux for Women aged 50-59 - 5 seconds ago
- Wellbutrin and Heartburn for Women aged 50-59 - 6 seconds ago
- Wellbutrin and Non-Cardiac Chest Pain for Women aged 50-59 - 6 seconds ago
- Wellbutrin and Gerds for Women aged 50-59 - 6 seconds ago
- Wellbutrin and Acid Reflux for Women aged 50-59 - 7 seconds ago
- Wellbutrin and Reflux Esophagitis for Women aged 50-59 - 7 seconds ago
- Wellbutrin and Pyrosis for Women aged 50-59 - 7 seconds ago